Clinical trials of disease stages in COVID 19: complicated and often misinterpreted

Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/26280

Full metadata record

DC Field	Value	Language
dc.contributor.author	Park JJH	-
dc.contributor.author	Decloedt EH	-
dc.contributor.author	Rayner CR	-
dc.contributor.author	Cotton M	-
dc.contributor.author	Mills EJ	-
dc.date.accessioned	2021-04-05T16:00:54Z	-
dc.date.available	2021-04-05T16:00:54Z	-
dc.date.issued	2020-10	-
dc.identifier.issn	2214-109X	-
dc.identifier.issn	2214-109X	-
dc.identifier.uri	http://hdl.handle.net/11375/26280	-
dc.publisher	Elsevier BV	-
dc.rights.uri	2	-
dc.subject	COVID-19	-
dc.subject	Clinical Trials as Topic	-
dc.subject	Coronavirus Infections	-
dc.subject	Data Interpretation, Statistical	-
dc.subject	Humans	-
dc.subject	Pandemics	-
dc.subject	Pneumonia, Viral	-
dc.subject	Randomized Controlled Trials as Topic	-
dc.subject	Research Design	-
dc.subject	Treatment Outcome	-
dc.title	Clinical trials of disease stages in COVID 19: complicated and often misinterpreted	-
dc.type	Article	-
dc.date.updated	2021-04-05T16:00:54Z	-
dc.rights.license	Attribution - CC BY	-
dc.identifier.doi	https://doi.org/10.1016/s2214-109x(20)30365-x	-
Appears in Collections:	Faculty Publications (via McMaster Experts)

Files in This Item:

File	Description	Size	Format
Clinical trials of disease stages in COVID 19 complicated and often misinterpreted.pdf Open Access	Published version	106.97 kB	Adobe PDF	View/Open